The oleocanthal-based homovanillyl sinapate as a novel c-Met inhibitor

Mohamed M. Mohyeldin(University of Louisiana at Monroe), Khalid A. El Sayed(University of Louisiana at Monroe)

Oncotarget

April 11, 2016

10.18632/oncotarget.8681

Cited by 21

Related Papers

Araguspongine C Induces Autophagic Death in Breast Cancer Cells through Suppression of c-Met and HER2 Receptor Tyrosine Kinase Signaling

|Marine Drugs|2015|38

Graviola (Annona muricata) Exerts Anti-Proliferative, Anti-Clonogenic and Pro-Apoptotic Effects in Human Non-Melanoma Skin Cancer UW-BCC1 and A431 Cells In Vitro: Involvement of Hedgehog Signaling

|International Journal of Molecular Sciences|2018|36

(−)-Oleocanthal Prevents Breast Cancer Locoregional Recurrence After Primary Tumor Surgical Excision and Neoadjuvant Targeted Therapy in Orthotopic Nude Mouse Models

|Cancers|2019|34

(−)-Oleocanthal Combined with Lapatinib Treatment Synergized against HER-2 Positive Breast Cancer In Vitro and In Vivo

|Nutrients|2019|31

The Marine-Derived Sipholenol A-4-O-3′,4′-Dichlorobenzoate Inhibits Breast Cancer Growth and Motility in Vitro and in Vivo through the Suppression of Brk and FAK Signaling

|Marine Drugs|2014|26